EEP Share Price Performance
Recent EEP News & Updates
No updates
Euroespes, S.A. Key Details
Last Reported Earnings
Dec 31, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.11
- Gross Margin
- 35.92%
- Net Profit Margin
- -29.49%
- Debt/Equity Ratio
- 68.3%
Euroespes, S.A. Competitors
About EEP
- Founded
- 1991
- Employees
- 39
- CEO
- WebsiteView website
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. It offers personalized and genomic medicine services for predictive, diagnostic, and therapeutic purposes. The company also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, clinical analysis laboratory, nursing, and cardiology. In addition, it researches and develops in the fields of biochemistry, health biotechnology, epigenetics, pharmacogenomics, and nutraceuticals. The company was founded in 1991 and is based in Corunna, Spain.
Spanish Market Performance
- 7 Days: -1.2%
- 3 Months: 3.4%
- 1 Year: 25.2%
- Year to Date: 16.6%
The Financials sector gained 4.6% while the market remained flat over the last week. As for the longer term, the market has risen 25% in the past 12 months. Looking forward, earnings are forecast to grow by 5.6% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading